ATLASPerspective Therapeutics (CATX) earnings date: Nov 9, 2026
Perspective Therapeutics (CATX) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026 (confirmed), after the close. Analysts expect EPS of -$0.24. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on CATX
| Last price | $1.03 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Perspective Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Perspective Therapeutics reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountCATX earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.24 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -5.7% |
| Average move around a report | ±5.4% (last 5) |
| Sector | Healthcare · Medical Devices |
Perspective Therapeutics earnings history: last 5 reports
Perspective Therapeutics last reported on Aug 10, 2026: EPS of -$0.22 against an estimate of -$0.27 (+18.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.27 | -$0.22 | +18.5% | Beat | +6.0% |
| May 11, 2026 | -$0.32 | -$0.25 | +21.9% | Beat | +0.3% |
| Mar 16, 2026 | -$0.34 | -$0.51 | -50.0% | Miss | -1.0% |
| Feb 20, 2026 | $1.57 | $1.50 | -4.5% | Miss | -0.9% |
| Jan 30, 2026 | $0.42 | $0.36 | -14.3% | Miss | +18.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CATX
See the fair value, the probability range and the earnings history of Perspective Therapeutics on its ATLAS page.
Perspective Therapeutics (CATX) stock analysisPlans from €3.99 a month.
Perspective Therapeutics earnings: frequently asked questions
When does Perspective Therapeutics (CATX) report earnings?
Perspective Therapeutics is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CATX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.24 per share (USD). Estimates can change before the report.
How often does CATX beat earnings estimates?
Of its last 5 reports with a recorded result, Perspective Therapeutics beat the EPS estimate 2 times; the average surprise was -5.7%. Past results do not predict the next one.
How much does CATX move around earnings?
Over its last 5 reports the stock moved an average of 5.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Perspective Therapeutics beat earnings estimates last quarter?
Perspective Therapeutics last reported on Aug 10, 2026: EPS of -$0.22 against an estimate of -$0.27 (+18.5% surprise), a beat.
How much does CATX usually move in a day?
On a normal trading day the ATLAS model puts CATX’s one-day range at about ±8.8%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer